Literature DB >> 3069872

Monoclonal antibody-based immunoenzymetric assays for quantification of human IgG and its four subclasses.

R G Hamilton1, R W Wilson, T Spillman, M Roebber.   

Abstract

A panel of 5 immunoenzymetric assays (IEMAs) has been developed for quantification of the total and four subclasses of immunoglobulin G (IgG) in human serum using IUIS/WHO documented monoclonal antibodies (MoAb). Human IgG specific MoAb was adsorbed to microtiter plates and used to capture IgG from serum. Peroxidase conjugated forms of polyclonal mouse anti-human IgG Fc or a mixture of 4 MoAb (anti-kappa, anti-lambda, anti-IgG Fc PAN and anti-IgG Fd PAN) were used as detection antibodies. Use of monoclonal antibody in chromatographically purified form was required for acceptable assay sensitivity (S) and working ranges (WR). All 5 IEMAs displayed good precision (intra-assay %CV less than 5%, inter-assay %CV less than 12%) and parallelism (inter-dilutional CV less than 20%). Both HP6069 or HP6070 (anti-IgG1 Fc) worked well alone or together as capture antibodies in the IgG1 IEMA: WR = 20-1250 ng/ml, S = 15 ng/ml. HP6002 (anti-gG2 Fc) alone or in combination with HP6014 (anti-IgG2 Fd) produced an IgG2 IEMA with a WR of 5-200 ng/ml and S of 5 ng/ml. HP6047 (anti-IgG3 hinge) alone generated a sensitive IgG3 IEMA with a narrow working range: WR = 2-50 ng/ml, S = 1.6 ng/ml. Both HP6025 and HP6023 (anti-IgG4 Fc) worked equally well alone and together to produce a useful IgG4 IEMA: WR = 8-250 ng/ml, S = 7.8 ng/ml. HP6017 (anti-IgG PAN Fc) was combined in an equal molar ratio with HP6046 (anti-IgG PAN Fd) to produce a total IgG PAN IEMA with a WR of 5-530 ng/ml and a sensitivity of 5 ng/ml. All 5 IEMAs fulfilled requirements for robust clinical immunoassays that permit the quantitation of human IgG and its 4 subclasses.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3069872     DOI: 10.1080/01971528808053217

Source DB:  PubMed          Journal:  J Immunoassay        ISSN: 0197-1522


  6 in total

1.  A novel X-linked combined immunodeficiency disease.

Authors:  E G Brooks; F C Schmalstieg; D P Wirt; H M Rosenblatt; L T Adkins; D P Lookingbill; H E Rudloff; T A Rakusan; A S Goldman
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

2.  Immunoglobulin G subclass response of localized juvenile periodontitis patients to Actinobacillus actinomycetemcomitans Y4 lipopolysaccharide.

Authors:  M E Wilson; R G Hamilton
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

3.  Opsonization of Actinobacillus actinomycetemcomitans by immunoglobulin G antibodies to the O polysaccharide of lipopolysaccharide.

Authors:  M E Wilson; P M Bronson
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

4.  Immunoglobulin G subclass response of juvenile periodontitis subjects to principal outer membrane proteins of Actinobacillus actinomycetemcomitans.

Authors:  M E Wilson; R G Hamilton
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

5.  Immunoglobulin G2 antibodies promote neutrophil killing of Actinobacillus actinomycetemcomitans.

Authors:  M E Wilson; P M Bronson; R G Hamilton
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

6.  Quantitative measurement of IgG to SARS-CoV-2 antigens using monoclonal antibody-based enzyme-linked immunosorbent assays.

Authors:  Ingrid Sander; Sabine Kespohl; Eva Zahradnik; Philipp Göcke; Ingolf Hosbach; Burkhard L Herrmann; Thomas Brüning; Monika Raulf
Journal:  Clin Transl Immunology       Date:  2022-01-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.